马达加斯加1型循环疫苗衍生脊灰病毒疫情应对策略与经验
2020至2023年马达加斯加发生1型循环疫苗衍生脊灰病毒(cVDPV1)疫情,成年人群受累明显且麻痹病例死亡率高。研究对2020年9月至2023年9月疫情展开描述性分析,共报告54例实验室确诊麻痹病例,另15例成人急性弛缓性麻痹被判定为脊灰兼容病例,其中死亡率56%。该国通过针对全人群及15岁以下儿童的疫苗接种运动、国家领导与社区动员等策略控制疫情。
要点
- cVDPV1疫情可显著累及成人,麻痹病例死亡率高。
- 15例成人兼容病例中死亡率56%,多因标本缺失或阴性。
- 针对成人开展接种运动并结合社区动员有助于控制疫情。
核心结论
- 马达加斯加cVDPV1疫情显示成人可显著受累且麻痹病例死亡率高,高接种覆盖率结合针对性创新与社区参与有助于成功控制疫情。
研究设计与样本
- 对2020年9月至2023年9月马达加斯加cVDPV1疫情进行描述性分析,回顾确诊及脊灰兼容病例的年龄分布、临床表现和结局,并记录疫情应对策略。
主要发现
- 研究期间共报告54例由cVDPV1引起的麻痹性脊灰确诊病例,包括两名表现为发热和麻痹的成人。
- 2022年2月至2023年3月,15例成人急性弛缓性麻痹病例因标本缺失(86%)或实验室阴性被国家脊灰根除委员会判定为脊灰兼容病例。
- 这些兼容成人病例的死亡率为56%。
关键数值与推荐
- 15例成人急性弛缓性麻痹病例中,86%因标本缺失、其余因实验室阴性被判定为脊灰兼容。
- 兼容成人病例死亡率为56%。
- 2022年2月至2023年3月期间,马达加斯加使用双价口服脊灰疫苗开展接种运动,在四个地区覆盖全人群,全国其余地区覆盖15岁以下儿童。
临床怎么用
- 在类似疫情中应考虑纳入成人接种策略,并加强标本采集以减少兼容病例分类的不确定性。
- 结合国家领导、战略动员和有效沟通提升成人接种覆盖率与风险认知。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: From 2020 to 2023, Madagascar experienced an outbreak of circulating vaccine-derived poliovirus type 1 (cVDPV1) that notably affected adults and was associated with high mortality among paralytic cases. This atypical epidemiological pattern required adapted surveillance approaches and tailored outbreak response strategies, including vaccination campaigns targeting adult populations. METHODS: We conducted a descriptive analysis of the cVDPV1 outbreak in Madagascar between September 2020 and September 2023. Epidemiological data on confirmed and polio-compatible cases were reviewed, including age distribution, clinical presentation, and outcomes. We also documented outbreak response strategies, particularly vaccination campaigns and operational innovations implemented to reach adult populations. RESULTS: A total of 54 confirmed cases of paralytic polio caused by cVDPV1 were reported during the study period, including two adults presenting with fever and paralysis. Between February 2022 and March 2023, 15 adult acute flaccid paralysis cases were classified as polio-compatible by the National Polio Eradication Committee due to missing (86%) or negative laboratory specimens. Mortality among these compatible adult cases was 56%. In response, Madagascar conducted vaccination campaigns using bivalent oral polio vaccine, targeting the entire population in four regions and children under 15 years in the rest of the country. Critical role of country leadership, strategic mobilization, and effective communication in driving success and influencing risk perception during the 2023 campaigns helped achieve high coverage among adults. CONCLUSIONS: The cVDPV1 outbreak in Madagascar demonstrated the potential for significant adult involvement and high mortality in polio outbreaks. High vaccination coverage combined with targeted innovations and strong community engagement contributed to successful outbreak control. These findings highlight the importance of inclusive vaccination strategies and tailored approaches in similar settings.
引用
- Djawe K, Aigbogun E, Zoumanigui JS, et al. Strategies and lessons learned from a type 1 circulating vaccine-derived poliovirus (cVDPV) outbreak affecting adult population: Madagascar, 2020-2023. Vaccine. 2026. PMID: 42556297. doi:10.1016/j.vaccine.2026.128987
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。